STXBP1 and Encephalopathy: With regard to the treatment of epilepsy induced by STXBP1 encephalopathy, about 25% of patients with STXBP1 encephalopathy were resistant to antiseizure medication (ASM) and more than 20% of patients with the condition required the use of two or more ASMs together [13].